Tempo Scan Pacific Tbk PT banner
T

Tempo Scan Pacific Tbk PT
IDX:TSPC

Watchlist Manager
Tempo Scan Pacific Tbk PT
IDX:TSPC
Watchlist
Price: 2 440 IDR -1.21% Market Closed
Market Cap: Rp11T

Multiples-Based Value

The Multiples-Based Value of one TSPC stock under the Base Case scenario is hidden IDR. Compared to the current market price of 2 440 IDR, Tempo Scan Pacific Tbk PT is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TSPC Multiples-Based Value
LOCKED
Unlock
Worst Case
Base Case
Best Case

Multiples Across Competitors

TSPC Competitors Multiples
Tempo Scan Pacific Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Tempo Scan Pacific Tbk PT
IDX:TSPC
11T IDR 0.8 7.3 4.1 4.1
US
Eli Lilly and Co
NYSE:LLY
837.7B USD 12.9 40.6 27.4 29.3
US
Johnson & Johnson
NYSE:JNJ
583.9B USD 6.2 21.8 15.1 18.6
CH
Roche Holding AG
SIX:ROG
248.4B CHF 4.1 19.4 11.5 13
UK
AstraZeneca PLC
LSE:AZN
228B GBP 5.2 29.9 16.6 23.3
US
Merck & Co Inc
NYSE:MRK
292.3B USD 4.5 16 9.9 12.1
CH
Novartis AG
SIX:NOVN
229.9B CHF 5.3 21.4 13.3 17
IE
Endo International PLC
LSE:0Y5F
237.1B USD 102.3 -81.1 375.3 941.3
US
Pfizer Inc
NYSE:PFE
157.9B USD 2.5 20.3 7.8 10.4
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK 3.3 10 7.4 8.7
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD 2.5 17.1 7.2 8.9
P/E Multiple
Earnings Growth PEG
ID
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Average P/E: 20.4
7.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.6
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.8
7%
3.1
CH
Roche Holding AG
SIX:ROG
19.4
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.9
26%
1.2
US
Merck & Co Inc
NYSE:MRK
16
14%
1.1
CH
Novartis AG
SIX:NOVN
21.4
14%
1.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -81.1 N/A N/A
US
Pfizer Inc
NYSE:PFE
20.3
22%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
10
1%
10
US
Bristol-Myers Squibb Co
NYSE:BMY
17.1
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ID
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Average EV/EBITDA: 45.1
4.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
27.4
22%
1.2
US
Johnson & Johnson
NYSE:JNJ
15.1
2%
7.6
CH
Roche Holding AG
SIX:ROG
11.5
6%
1.9
UK
AstraZeneca PLC
LSE:AZN
16.6
13%
1.3
US
Merck & Co Inc
NYSE:MRK
9.9
3%
3.3
CH
Novartis AG
SIX:NOVN
13.3
5%
2.7
IE
E
Endo International PLC
LSE:0Y5F
375.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
-9%
N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.4
1%
7.4
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett